Jagsonpal Pharma Extinguishes 16 Lakh Equity Shares Post Buyback

Jagsonpal Pharmaceuticals Limited has officially extinguished 16,00,000 equity shares that were acquired through its recent buyback program. This action, in compliance with SEBI regulations, reduces the company's total issued share capital. The pre-buyback share capital stood at 6,71,39,150 equity shares amounting to ₹13,42,78,300. Post-extinguishment, the share capital is now 6,55,39,150 equity shares, valued at ₹13,10,78,300. Depository services have confirmed the extinguishment, and the company has provided necessary certifications as per SEBI's Buyback Regulations.